Company Panaxia Labs Israel Ltd TEL AVIV STOCK EXCHANGE
Equities
PNAX
IL0011043630
Business Support Services
Business Summary
Sales per Business
ILS in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Medical Cannabis Products
94.4
%
| 72 | 85.6 % | 37 | 94.4 % | -47.97% |
Production Services, Storage and Distribution
5.6
%
| 12 | 14.4 % | 2 | 5.6 % | -81.76% |
Sales per region
ILS in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Israel
67.3
%
| 84 | 100.0 % | 27 | 67.3 % | -68.26% |
Europe
32.7
%
| - | - | 13 | 32.7 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 19-09-30 |
Assi Rotbart
CHM | Chairman | 49 | 19-09-30 |
Director of Finance/CFO | 66 | 22-12-27 | |
Eran Goldberg
CTO | Chief Tech/Sci/R&D Officer | 49 | 19-09-30 |
Joseph Ginossar
AUD | Comptroller/Controller/Auditor | 65 | 18-05-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 54 | 21-12-28 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 16-07-20 |
Michal Sapir
BRD | Director/Board Member | 66 | 22-03-16 |
Rinat Gazit
BRD | Director/Board Member | 54 | 19-10-30 |
Assi Rotbart
CHM | Chairman | 49 | 19-09-30 |
Dadi Segal
CEO | Chief Executive Officer | 48 | 19-09-30 |
Rinat Gazit
BRD | Director/Board Member | 60 | 19-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 406,640 | 250,022 ( 61.48 %) | 0 | 61.48 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+14.58% | 70.29B | |
+6.71% | 17.8B | |
+23.57% | 13.68B | |
+7.64% | 13.15B | |
+19.52% | 10.13B | |
-24.66% | 6.51B | |
-6.71% | 5.86B | |
+0.31% | 5.14B | |
-0.13% | 4.99B |